What's this leading broker saying about the Qantas share price?

Qantas shares are flying in the green today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Qantas Airways Ltd (ASX: QAN) share price has walked through today's session in the green, currently 3.05% up on the day.

This continues a solid gain over the past week, where Qantas shares have climbed 13.6% higher in this time.

A woman holds her arms out as a plane flies overhead

Image source: Getty Images

What's behind the Qantas share price lately?

There have been several tailwinds behind the Qantas share price over the last week or so.

Despite reporting a $2.3 billion pre-tax loss in its FY21 results, investors seem confident that the company will recover strongly as the restrictions on domestic and international air travel are gradually lifted. The Qantas share price is up over 13% since reporting its FY21 earnings despite the mixed results.

Adding fuel to the engine, Qantas recently outlined a plan to potentially restart international flight routes from as early as December.

The company is confident the 80% vaccination target will be met in that month and is basing its decision on the target being reached.

Travellers could then fly to other low-risk COVID-19 countries, such as Singapore and the United Kingdom.

What are analysts saying?

One leading broker, JP Morgan, believes in the recovery of Qantas and is bullish on Qantas shares.

According to a note, the broker was happy with Australia's vaccine uptake fuelling a recovery in the Qantas share price. It has reiterated its overweight rating on Qantas shares and increased its price target by 10 cents to $5.80.

This implies a potential upside of around 11% from the current market price of $5.24.

What else did the broker say?

Analysts at the investment bank believe Qantas is well-positioned to weather the storm caused by the pandemic. Speaking on what measures Qantas has taken, JP Morgan said the company had "taken material costs out of its business, around $1.1 billion of which are likely to be ongoing savings from FY23".

It also added that it favoured Qantas' "high proportion of earnings from domestic and loyalty at 70–75% of earnings, its strong relative balance sheet positioning and more favourable competitive position – both domestically and internationally".

In light of this commentary, the broker has updated its modelling to reflect current market conditions. It now assumes "domestic capacity is at 77% in FY22 and back to above 2019 levels in FY23". This forecast is also in line with Qantas' guidance.

On the international side, the broker estimates that FY22 capacity will reach 25% of 2019 levels, and then rapidly increase to 70% by FY23. It believes international capacity will "approach pre-COVID-19 levels by FY24".

Bringing it all together, JP Morgan believes this could be a buying opportunity for investors moving forwards.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »